Fortell AI Hearing Aids vs JLab Hear OTC

The Fortell AI Hearing Aids are a premium prescription behind-the-ear device priced at $6,800, earning an A grade with a SoundScore of 6.0/5 in HearAdvisor lab testing—an exceptional result that places this device at the top of the prescription hearing aid category. Speech performance is where the Fortell AI truly distinguishes itself. Speech in noise scores an outstanding 6.0/5, a full 3.89 points above the category average of 2.11/5—the kind of margin that represents a meaningful difference in challenging listening environments like restaurants or group conversations. Speech in quiet also excels at 4.6/5, sitting 1.20 points above the category average. Music streaming performs strongly at 4.2/5, coming in 1.44 points above average for the category. The device does have a notable limitation: own-voice comfort scores just 1.5/5, falling 1.20 points below the category average. This low absolute score suggests wearers may notice occlusion effects when speaking. Feedback handling is excellent at 4.8/5, essentially matching the category average. Best suited for: Users who prioritize understanding speech in difficult listening situations and value streaming quality, and who can tolerate potential own-voice occlusion. Given the premium price point, buyers should weigh whether the exceptional speech-in-noise performance justifies the investment compared to alternatives like the Oticon Intent or Oticon Zeal, which offer strong performance at lower price points.

The JLab Hear OTC is a budget-priced OTC hearing aid released in 2024, earning a B grade with a SoundScore of 3.5/5 in our lab testing. At $100, it represents one of the most affordable entry points into the OTC hearing aid market, ranking #36 of 65 devices in its category. This visible-in-ear device delivers a distinctive performance profile with clear strengths and weaknesses. Its standout feature is excellent music streaming quality, scoring 4.6/5—a remarkable 2.68 points above the category average. Feedback handling is equally impressive at 5.0/5, meaning users can expect stable performance without whistling during daily activities. These results suggest JLab leveraged its audio expertise from consumer earbuds in developing this product. However, speech clarity presents challenges. Speech in quiet scored 2.1/5 (0.67 points below category average), while speech in noise scored 1.0/5 (0.46 points below average). Own-voice comfort also measured low at 1.8/5. These limitations are significant for users prioritizing conversation clarity, which is typically the primary reason people seek hearing aids. The JLab Hear OTC is best suited for budget-conscious consumers who value music and media streaming alongside basic amplification, rather than those needing maximum speech intelligibility. Features include rechargeable batteries, iPhone and Android streaming, and hands-free functionality. Buyers seeking stronger speech performance in this price range may want to compare options like the higher-scoring Elehear Beyond or Apple AirPods Pro 2.